
About
the LIMSource
This site provides detailed information about Laboratory Information Management
Systems (LIMS)
Applications
Links to various application-specific LIMSource pages, such
as pharmaceutical, environmental, biotech, etc.
Calendar
Conferences, trade shows, seminars, etc. that highlight LIMS, informatics,
and lab data management issues
Classified Ads
A careers section of classified ads from organizations seeking LIMS professionals
Guest Book
If you are new to this site, please register with the Guest Book. Registrants
receive free LIMSource online newsletter
Library
Books, newsletters, and magazines as well as the LIMSzine and a list of "Interesting
Places to Visit"
LIMS/Letter
Details about the LIMS/Letter, including an archive of all past issues
and an online ordering form
LIMS
Primer CD
Unique CD-ROM delivers a capsule look at LIMS, from tutorials and advice,
to selected LIMS/Letter articles, to a short list of top LIMS vendors
LIMS
Products & Services
Comprehensive list of LIMS, and lab data automation products and services
available from vendors, consultants, and service/support providers
User Community
Lists of relevant associations as well as details about the LIMS Institute
and LIMS Mailing List User Group
What's New
About What's News
What's New in the Industry
What's New in this Web Site
Copyright
© LIMSource.
All Rights Reserved
Legal Notice.
•
LIMS Market to Grow to $366 Million with Huge Upside Potential
• Desert
Moon Technologies Finalizes Acquisition of Forensic Technology LabPlus Technologies
Operations
• PESC Replaces a Legacy LIMS with StarLIMS
• L.i.M.S.
Announces Key Leadership Appointment
•
Autoscribe Announces StabilityTracker
to Track and Report the Status of Pharmaceutical Stability Testing
• SampleManager
IDI 2003 from Thermo Electron Enhances Integration Between LIMS and the Enterprise
• Thermo Electron Extends Relationship with IBM
to Enterprise LIMS Business
• Accelerated Technology Laboratories will Exhibit at
the Eastern Analytical Symposium 2003
•
Bio-Rad Offers Free, Downloadable Chemistry Drawing, Publishing,
and Spectroscopy Applications for Academia
• Bio-Rad’s KnowItAll 3.0 Offers Enhanced Features
for ADME/Tox & MS
• SAP Ships Solution for Master Data Management
• Novo
Nordisk IT to Become Certified Service Provider for NuGenesis Technologies
Products
• Scientific Software Recognized as Top 25 Company Fourth
Year in a Row
• Scientific Software Announces Free Software Utility
• Scientific Software Announces Release of CyberLAB
KES in Kanji
• ChemSW's New Chemical Inventory System Module Links
Unlimited Number of Documents
• CSols and Wavefront Software Announce New Alliance
• LabCon Delivers New Wireless Interface Connector
Solution for Interfacing RS 232 Instruments
• Labtronics'
NEXXIS Integrates RS232 Instruments with NuGenesis SDMS
• Labtronics B.V. Expands in Europe
• SQassim Cement Company and ABB Sign Contract for
PL-1 Upgrade Project
• GAO Recommends Better Tracking of
Minorities in Pediatric Trials
•
Thermo Offers New Generation of ActiveApps for Spectral
Data Processing
•
Thermo Electron Publishes New Brochure on eRecordManager
Data Archival Solution
• Autoscribe
Releases Matrix CRS - Compound Registration Systems
• Autoscribe
Announces Configurable Approach to Managing
Employee Training Needs
• Algorithme
Pharma Purchases InnaPhase Corporation's Watson LIMS in Canada
• ABB
and Nicklas & Partner Join Together to Provide Collaborative Production
Management Solutions
• Bio-Rad Announces New Software Technology
for In-Silico ADME/Tox Consensus Modeling
• Bio-Rad's KnowItAll Informatics System 2.2 Offers
Enhanced Features for NMR, MS, and 3D Structure Drawing
• JEOL
USA and ACD/Labs Introduce Automated Structure Elucidation for NMR
• Agilent
Technologies to Integrate its HPLC and ChemStation Solutions with Advanced
Chemistry Development's AutoChrom and ChromGenius Software
• Agilent Technologies
Reports Third-Quarter 2003 Results; Company on Track to Achieve Profitability
in Fourth Quarter
• Labtronics
Announces Software Upgrade for Technicon AAII and Alpkem RFA Instruments
• Caliper Technologies Acquires
Zymark Corporation
• Oracle
Introduces Several New Products
•
SAP Expands mySAP Customer Relationship Management
(mySAP CRM)
•
SAP Supports WS-I Basic Profile 1.0
•
FDA Applies Risk-Based Approach to Preapproval Inspections
•
FDA's cGMP Initiative Aims to Boost Safety, Efficiency
•
FDA Releases Part 11 Guidance, More Revisions May
Come
•
FDA, GPhA Launch ANDA Review
Cycle Initiative
LIMS
Market to Grow to $366 Million with Huge Upside Potential
The worldwide market for Laboratory Information Management Systems (LIMS)
is expected to grow at a Compounded Annual Growth Rate (CAGR) of 4.8 percent
over the next five years. The market for these commercial-off-the-shelf
(COTS) applications is projected at $290.3 million in 2003 and is forecasted
to be $366 million in 2008, according to a new ARC Advisory Group study. Manufacturers
of all sizes across industry boundaries are recognizing that home grown systems
may not be cost effective. “The perception that commercial LIMS
solutions require extensive customization is outdated. Manufacturers
are displaying an increased willingness to implement moderately customized,
out-of-the-box solutions to decrease their LIMS Total Cost of Ownership (TCO),”
according to Senior Analyst Paula Hollywood, the principal author of ARC’s
“Laboratory Information Management Systems (LIMS) Worldwide Outlook.”
This study projection is for the commercial LIMS hardware, software, and services
market. When home grown LIMS solutions are included, ARC estimates the
potential for this market to be between $550 to $750 million dollars; i.e.,
two to three times current forecasts. A huge upside opportunity is the
conversion of these custom solutions — with their inherent high total
cost of ownership to out-of-the-box solutions. Recognizing the difficulty
convincing users to ditch their home grown systems for packaged software,
these numbers are not part of the forecast. But, if someone can tap
into this area, this market has great upside potential. Additional information
on this market study can be found at http://www.arcweb.com/res/lims.
Desert
Moon Technologies Finalizes Acquisition of Forensic Technology LabPlus Technologies
Operations
DMT-LabPlus, Inc. (DMT) and Desert Moon Canada Holdings, Inc.Technologies
Company, each a subsidiary of Desert Moon Technologies, Inc. a life-sciences,environmental,
and health an information management solutions firm, and Forensic Technology
WAI, Inc. (FTI), a worldwide leader in forensics LIMS, ballistic information
systems, and evidence management systems, have announced that DMTC has acquired
the LabPlus Technologies worldwide LIMS software business from FTI. As a result
of this acquisition, the worldwide LabPlus Technologies software business
will become a division of DMCH DMT with headquarters in Phoenix, Arizona,
USA. Canadian offices will remain in Montreal, Quebec and will be responsible
for the LIMS software business product evolution, development and North American
customer support. The European offices will be relocated, and the support
team will remain within Dublin, Ireland. Ireland and will be responsible
for providing professional services and customer support to the European and
Middle Eastern customer base. DMCH DMT will retain the LabPlus product
brand and all customers and partners but will change the company name to DMT-LabPlus,
Inc. Announcements for expansion plans within key US markets are expected
in the coming weeks. “As more companies begin to embrace the importance
of and organizational value gained from enterprise-wide laboratory information
solutions, we want to be positioned as the visionary responding to the industry’s
changing business needs. Acquiring LabPlus Technologies allows us to
leverage our depth and expertise with laboratory analytical support, information
intelligence and reporting with laboratory workflow automation and project
management”, said Ron Hardin, President and CEO of DMT. “This
gives our customers one more reason to choose DMT as their software provider
of choice for complete laboratory solutions and moves us closer to our strategic
goal of being the preferred full life-cycle solution from discovery through
manufacturing. Our integrated approach to gathering, managing, analyzing and
sharing information uniquely positions us in the market place and is a clear
distinction between us and our competition. We will continue to build
cost-effective solutions and seek out technology alliances that minimize business
service interruption during integration as well
as reduce the cost of ownership. Most important, however, is that we instill
confidence and demonstrate value for the existing LabPlus customer base during
the transition period. We want to ensure our new customers that in joining
the DMT team they will see no interruption to their existing support services,
and that they will benefit greatly from forthcoming releases to the product,”
said Mr. Hardin. For details, visit http://www.dmteks.com.
PESC Replaces a Legacy LIMS with StarLIMS
Pacific Environmental Science Centre (PESC) has replaced their legacy LIMS
with a StarLIMS solution. With multi-functionality required, covering 105
applications, and with 12 functional areas of the laboratory and around 500,000
tests conducted per year, Richard Stubb, Head of Scientific Support at the
Pacific Environmental
Science Centre (PESC) describes the migration of 25 years of database programming
within 117 days in a PDF available from the L.i.M.S. Ltd web site at http://www.starlims.com/PESC_DataSheet.pdf.
L.i.M.S.
Announces Key Leadership Appointment
L.I.M.S. (USA) Inc. has announced the appointment of Jeff Ferguson, as its
new Chief Operating Officer. In Jeff's new position he will direct the company's
product development, general management of sales, marketing, professional
services, and operations. Jeff brings the company over 15 years of industry
expertise combining operational know-how and leadership. For details, visit
http://www.starlims.com/KLA.htm.
Autoscribe
Announces StabilityTracker
to Track and Report the Status of Pharmaceutical Stability Testing
Autoscribe has announced the availability of a program to assist stability
groups track and report the progress of FDA mandated trials. Recently Autoscribe
introduced Matrix Stability 2.0, the latest version of their powerful stability
data management system, which can be supplied as a stand-alone product or
as an integrated module of Matrix Plus LIMS. This new release contains comprehensive
functionality to develop, approve, execute and record all aspects of a stability
study from protocol definition to result reporting. Autoscribe has developed
StabilityTracker in response requests from companies that already have a validated
LIMS, which supports their QC testing but that has limited functionality for
their stability group. This new stand-alone product supplements but does not
replace the existing LIMS. It records all details concerning a study
and the multiple lots that are part of the study, including formulation and
packaging information. StabilityTracker prompts when pulls are due and displays
which tests must be carried. It records and reports when the pulls have been
made and when tests are completed. It also records who carried out each activity.
It is a much more secure and compliant way of recording this information than
discrete Excel spreadsheets. In addition, StabilityTracker contains a complete
audit trail and access to all functions and data is tightly controlled. It
is developed by Autoscribe in an ISO 9002 certified process using modern lifecycle
techniques. Full requirements, design and testing documentation is available;
audits are welcomed.For details, visit http://www.autoscribe.co.uk.
SampleManager IDI 2003 from Thermo Electron
Enhances Integration Between LIMS and the Enterprise
Thermo Electron Corporation has released SampleManager IDI 2003, the latest
generation of software integrating Thermo’s SampleManager LIMS and SAP
AG’s R/3 Enterprise, the leading Enterprise Resource Planning (ERP)
system. Combining Thermo’s flagship LIMS with SAP AG’s R/3 Enterprise
gives customers an enhanced ability to provide consistent quality-related
information to the entire enterprise. To leverage the full benefits of modern
ERP solutions, organizations require automated access to all aspects of their
business, including the process laboratory. Organizations interfacing LIMS
with an ERP system can expedite the data flow between the laboratory and manufacturing,
streamline data handling, and integrate data collection and reports. SampleManager
IDI, the first LIMS interface to be certified by SAP AG, was developed to
address the needs of large-scale production facilities where integration with
ERP systems is a business requirement. SampleManager IDI 2003 enables SAP
customers to fully utilize new functionality in R/3 Enterprise Quality Management
(QM) module, while benefiting from the use of a specialist, functionally rich
‘enterprise-centric’ LIMS product within the laboratory. A simple
point-and-click interface allows creation of data through SampleManager or
R/3 Enterprise, and the ability to easily map critical business needs into
the LIMS database. Graphical table-driven SAP objects and user-driven mapping
procedures ensure easy access to accurate information in the LIMS, in a flexible,
easily understood format. SAP customers upgrading to a new version or customizing
their R/3 Enterprise deployment can update the table-driven SAP objects in
SampleManager IDI in a matter of minutes. For details,
visit http://www.thermolabsystems.com.
Thermo
Electron Extends Relationship with IBM to Enterprise LIMS Business
Thermo Electron Corporation hasannounced that it has expanded its relationship
with IBM to pursue co-operative business opportunities in the global LIMS
marketplace. Thermo and IBM will work together to create solutions that leverage
Thermo’s LIMS expertise with IBM eServer system architecture. An intensive
cycle of system testing was recently performed on Thermo’s Nautilus
and SampleManager LIMS running on an IBM eServer xSeries 235. Over 19,000
individual tests were performed using a combination of automated and manual
scripts between April and June 2003. Thermo reports that the processing power
and capacity of the IBM server, hosting the latest versions of both LIMS servers
and databases, provided a smooth and highly efficient testing result. IBM
hardware is now an integral part of Thermo’s LIMS testing environment,
providing increased assurance of the resilience and quality of the Thermo/IBM
integrated solution. With an installed base of over 1,100 systems and around
45,000 daily users worldwide, Thermo’s SampleManager LIMS is one of
the most established and industrially robust LIMS on the market. The new collaboration
builds on an extensive relationship between Thermo and IBM to deliver joint
solutions in such areas as data archiving, using Thermo's eRecordManager and
IBM Tivoli Storage Manager, and processing proteomic data using Thermo's SEQUEST
Cluster software and IBM's eServer 1350 Linux Cluster. For
details, visit http://www.thermolabsystems.com.
Accelerated
Technology Laboratories will Exhibit at the Eastern Analytical Symposium 2003
Accelerated Technology Laboratories, Inc. (ATL), a premier supplier of LIMS,
will exhibit new features in Sample Master Pro XP and ScreenIT Pro LIMS at
the Eastern Analytical Symposium, EAS 2003. The annual conference is scheduled
for November 17-20, 2003 in Somerset, New Jersey. Sample Master Pro XP LIMS
has a new look and feel patterned after Microsoft’s XP products. New
features include: Time Tracking and Customer Relationship Management modules,
new EDD formats, integrated e-mailing, expanded capability for instrument
integration and the ability to include GPS coordinates and multiple locations
for a sampling site, with a graphical interface. ScreenIT Pro LIMS is a user
configurable LIMS that is ideal for raw materials and manufacturing laboratories.
New features include: enhanced Workload, Production and Backlog Reports, Certificates
of Analysis, SPC Charts and multiple level specifications with visual quality
alerts and e-mail notification. In addition, ATL, Inc. will be presenting
three technical papers at the Eastern Analytical Symposium. For details, visit
http://www.atlab.com or http://www.eas.org.
Bio-Rad Offers Free, Downloadable Chemistry Drawing,
Publishing, and Spectroscopy Applications for Academia
Bio-Rad Laboratories, Inc. has announced the release of the KnowItAll Informatics
System, Academic Edition, a free, downloadable, fully-functional software
package for chemical structure drawing, publishing, and spectroscopic analyses.
The KnowItAll Academic Edition, available at http://academic.knowitall.com,
enables users to draw structures in 2D and 3D, perform IR and Raman functional
group analysis, process IR, NMR, and Raman spectra, access the renowned Sadtler
spectroscopy handbooks, and generate high-quality laboratory reports. This
software is offered exclusively to the academic community as a part of Bio-Rad’s
continued commitment to promote learning and research initiatives in academia,
providing the latest and most advanced software technology and databases for
inquiry-based learning in organic and analytical chemistry. The software and
database tools in the KnowItAll Academic Edition can be used by students,
teachers, and researchers at any level. They work well in the organic chemistry
curriculum to teach students fundamentals of structure & bonding and spectroscopy
as well as in the analytical chemistry curriculum to teach advanced spectroscopy
and spectrometry techniques. The KnowItAll Academic Edition includes free
on-line training movies to teach professors and students how to use and get
the most out of the software. For details, visit http://www.informatics.bio-rad.com.
Bio-Rad’s KnowItAll 3.0 Offers Enhanced Features
for ADME/Tox & MS
Bio-Rad Laboratories, Inc. has announced the release of the KnowItAll Informatics
System version 3.0, a major upgrade to the industry's leading software &
database solutions for spectroscopy, cheminformatics, and ADME/Tox prediction.
Highlights and additions in the new release include a new ADME/Tox Consensus
Modeling Environment to optimize the combined results of multiple in silico
ADME/Tox models; the world’s first ADME/Tox Consensus Modeling Environment
through the use of a new application called ValidateIt that enables the user
to train multiple continuous variable models against a set of chemical structures
with known values; new Blood Brain Barrier, Plasma-Protein Binding, Mutagenicity,
Water Solubility, Log P and Log D models; and a new MS Documentation tool
to create a fragmentation line and display the masses of two fragments. For
details, visit http://www.informatics.bio-rad.com.
SAP Ships Solution for Master Data Management
Novo
Nordisk IT to Become Certified Service Provider for NuGenesis Technologies
Products
NuGenesis Technologies Corporation, a market leader in scientific data management,
and Novo Nordisk IT, a leading pharmaceutical IT consultant and developer
in Europe, have announced that Novo Nordisk IT will become a Certified Service
Provider for the NuGenesis Scientific Data Management System (SDMS) within
the Nordic territories. When the certification process is complete, Novo Nordisk
IT consultants will provide complete NuGenesis SDMS project management services
including system design, implementation, integration, validation and training.
Certification is expected to be complete by the end of 2003. NuGenesis Technologies
will continue to offer expert consulting in the Nordic region directly but
customers now have a choice of local service representation. For details,
visit http://www.novonordisk-it.com
or http://www.nugenesis.com.
Scientific Software Recognized as Top 25 Company
Fourth Year in a Row
Scientific Software, Inc. has been recognized for the fourth year in a row
as one of the Top 25 East Bay software companies by the East Bay Business
Times. Scientific Software, Inc. is a world leader in the development, sale
and support of software systems to the scientific community. With over 55,000
worldwide installations, the company's EZChrom Elite Chromatography Data System
is used in a wide range of markets such as pharmaceutical, environmental,
chemical, and food analysis. The company's CyberLAB Knowledge Engineering
System is used by leading pharmaceutical and biotechnology companies providing
an enterprise-wide solution for information collaboration, data management,
regulatory compliance and knowledge engineering. For details, visit http://www.scisw.com.
Scientific
Software Announces Free Software Utility
Scientific Software, Inc., a provider of software solutions to the scientific
community, has released a new software utility that is available to all interested
parties at no charge. The AIA FileViewer is a software utility that provides
a graphic application to all AIA (Analytical Instrument Association) chromatography
data files. This stand-alone application lets users view AIA files (net CDF
files) directly, without having to read the file into a proprietary Chromatography
Data System. Once opened by the AIA FileViewer, users can perform additional
graphic operations to overlay multiple traces, scale, and render the AIA file
into a format suitable for cut/paste operations into Microsoft applications.
The AIA FileViewer can be downloaded directly by accessing the Scientific
Software web site at http://www.scisw.com.
Scientific
Software Announces Release of CyberLAB KES in Kanji
Scientific Software, Inc. has released its CyberLAB Knowledge Engineering
System in Kanji. The new release will allow users in Japan to
take full advantage of CyberLAB features in their native language. The CyberLAB
Knowledge Engineering System is a secure, web-based system designed to capture
and warehouse all the electronic records across the enterprise in one scalable
architecture. Users can create laboratory reports and search, retrieve, data
mine, and archive any type of an electronic record such as instrumentation
raw data, reports, spreadsheets, documents, presentations and image files.
CyberLAB assists organizations to become compliant with FDA regulations when
required. Built using standard web technology, CyberLAB is expandable from
a single user system to global multi-site implementations enabling global
research collaboration and data sharing. For details, visit http://www.scisw.com.
ChemSW's
New Chemical Inventory System Module Links Unlimited Number of Documents
ChemSW, Inc. has announced a new Internal Document Storage Module for its
CISPro CIS Chemical Inventory System. This new feature saves time and
eliminates paper trail steps by linking all documents that relate to a particular
chemical container in the inventory tracking system. Critical documents
include Certificates of Analysis and MSDS, as well as any testing results.
"In a traditional system, numerous paper documents are generated around
a particular chemical lot," explains Brian Stafford, President of ChemSW.
"It's impossible to ensure that these documents stay with a chemical
container as it moves throughout a facility. The result is that information
is not available when it's needed. This new module keeps all necessary
information in the inventory tracking system, at the user's fingertips."
The new software module is available for any CIS Pro Chemical Inventory System,
from desktop to enterprise and web-enabled versions. ChemSW's CIS Pro
was developed specifically for the management and tracking of laboratory chemicals
in regulated environments. ChemSW is a leading provider of chemical and biochemical
inventory management systems, MSDS systems and other chemistry laboratory
software and services. For details, visit http://www.chemsw.com.
CSols and Wavefront Software Announce New Alliance
CSols and Wavefront Software have announced that they are partnering to market
and sell products and services encompassing CSols Links for LIMS. This new
alliance benefits analytical laboratories by providing advanced solutions
that streamline data acquisition and management, and enable integration of
networked laboratory data systems which includes chromatography data systems
(CDS), instruments and LIMS. Instrument-CDS-LIMS integration enables
improved regulatory compliance and productivity in the drug discovery, development
and manufacturing process. Links for LIMS software provides a seamless, bi-directional
interface between networked data systems and any LIMS by using plug-in drivers
for all major commercial LIMS. This allows users of networked data systems
to integrate their laboratory instruments and chromatography data with their
enterprises’ LIMS in accordance with common regulatory standards such
as GLP, GMP or the US Food and Drug Administration’s ruling on electronic
records and signatures (21 CFR Part 11). Work lists can be uploaded
from the LIMS to the CDS. The software can automatically build sequences and
report results to LIMS, and can also automate most manual data manipulation
and review activities. The software is scaleable from a single instrument
to the largest enterprise systems. CSols’ Links for LIMS can also
integrate other (non-CDS) instruments with LIMS. For details, visit http://www.wavefrontsoftware.com
or http://www.csols.com.
LabCon
Delivers New Wireless Interface Connector Solution for Interfacing RS 232
Instruments
During recent years, instrument interfacing has been concentrated on instruments
such as like ICPs, CDS and flow analyzers which produce large amounts of data.
The return on investment for interfacing is often calculated based on an increase
of quality and time savings on retyping of results. As complex instruments
do produce more results, more retyping is involved. RS 232 instruments suffer
from the high fixed cost of interfacing. The fact that almost all "simple"
instruments require an individual PC, eating expensive bench space is the
next reason for the lack of interfacing these type of instruments. Labcon
Engineering's Wireless Interface Connector (WIC) allows the laboratory to
connect their serial instruments to a low cost computer for an affordable
price. Distance might be as far as 100 meters. Labcon's WIC allows laboratories
to take their computers out of the fume cupboard, wetlab or dusty environment
and place them in a more clean area. For details, visit http://www.lab-eng.com.
Labtronics' NEXXIS Integrates RS232 Instruments
with NuGenesis SDMS
NEXXIS, from Labtronics Inc, provides a powerful solution for NuGenesis SDMS
users who want to include data from RS232 and TCP/IP instruments in their
data archiving system. NEXXIS not only collects data it also controls instruments,
records the analyst's observations, comments and descriptions and creates
reports that can be sent directly to NuGenesis SDMS. NEXXIS can also control
workflow on these instruments and ensure that each step of an SOP is carried
out correctly. Interactive user screens can be customized to address SOP requirements
such as instrument calibration, analysts' qualifications and suitability of
the equipment. Each step of the analysis can be clearly defined and controlled.
NEXXIS reports can include raw instrument data, calculated data, data previously
stored in NuGenesis SDMS, or manually entered information. Results are automatically
and filelessly reported directly to NuGenesis SDMS in virtually any format
including PDF, Word, Excel or HTML. The combination of NuGenesis SDMS and
NEXXIS creates a robust data management and archival system for RS232 and
TCP/IP based instruments. For details, visit http://www.labtronics.com.
Labtronics B.V. Expands in Europe
Labtronics Inc. has announced that their European office, Labtronics B.V,
is expanding and moving to larger premises in Gouda, The Netherlands. Established
in April of 2000, Labtronics B.V. has grown rapidly, providing and implementing
Labtronics’ entire range of instrument interfacing solutions throughout
Europe. The move allows Labtronics B.V. to provide improved support and training
facilities for their growing customer base. As of September 11, 2003, Labtronics
B.V. can be reached at Hanzeweg 10, 2803 MC Gouda, The Netherlands. For details,
visit http://www.labtronics.com.
SQassim
Cement Company and ABB Sign Contract for PL-1 Upgrade Project
ABB,a global power and technology group, has announced that Qassim Cement
Company (QCC) located in Buraydah, Kingdom of Saudi Arabia and ABB Contracting
Co. Ltd, Saudi Arabia, signed a contract for change of Power Supply to the
plant and upgrade of Electrical and DCS (Distributed Control system) to Production
Line No. 1. The contract was signed in the boardroom of QCC in Buraydah on
12th August 2003. The contract is to change the power supply to the Cement
Production Line No. 1 (PL1) from QCC owned and operated, aged 50 Hz diesel
power station to the 60 Hz public grid system of Saudi Electricity Company
(SEC) and upgrade of the existing PL-1 Electrical & Control System. The
scope of work on a turnkey basis includes provision for SEC power supply to
all QCC Production Lines and upgrade of PL-1 Electrical & Control System
to continuously operate at 60Hz frequency by installing 33kV Central Switchgears,
Static Frequency Converter as well as state of the art technology incorporating
Variable Speed Drives and IndustrialIT Control System. For details, visit
http://www.abb.com.
GAO Recommends Better Tracking of Minorities in
Pediatric Trials
Drugmakers could face the loss of six months of additional marketing exclusivity
for pediatric indications if they don’t identify children enrolled in
clinical trials by using racial and ethnic definitions laid out in an agency
draft guidance earlier this year. The U.S. General Accounting Office (GAO)
cited that potential consequence in a report recommending improvements to
the FDA’s ability to monitor minority inclusion in pediatric trials.
GAO found that in trials conducted for 23 drugs, which later were granted
additional marketing exclusivity, 14 percent of the pediatric participants
were not identified by race or ethnicity. The aim of such identification is
to track drug effectiveness and adverse events that might differ across racial
and ethnic groups. In comments on the draft version of the GAO report, the
FDA said it recently had begun telling trial sponsors to categorize pediatric
patients by race and ethnicity. The FDA suggested in a draft guidance, released
in January, that drugmakers use suggested categories when collecting race
and ethnicity data in trials. But drugmakers commenting on the draft guidance
have criticized the categories as U.S.-centric and inappropriate for international
research trials. For details, visit http://www.fda.gov.
Thermo
Offers New Generation of ActiveApps for Spectral Data Processing
Thermo Electron
Corporation has announced a new series of add-on processing software
applications, called ActiveApps, for its leading spectral data processing
package, GRAMS/AI. Thermo’s ActiveApps extend the capabilities of GRAMS/AI
to allow faster, more powerful processing and unrivalled flexibility. Based
upon Microsoft's latest ActiveX technology, ActiveApps allow spectroscopists
to perform advanced processing techniques, such as the transferal of data
files between applications, a variety of multi-file operations, advanced quantitative
analysis and for the prediction of spectral data files. Each of the ActiveApps
offers features to enhance the user experience and improve user productivity.
New client interfaces and a high level of configurability mean that users
are now able to set up their own menus and toolbar buttons in each of the
ActiveApps, thereby customizing the interface to suit the way each user works.
For details, visit http://www.thermolabsystems.com.
Thermo Electron Publishes New Brochure on eRecordManager
Data Archival Solution
Thermo Electron Corporation has announced the availability of a new brochure
focused on its laboratory informatics solution, eRecordManager. The eight-page
brochure provides readers with a comprehensive overview of the system’s
functionality for data storage, searching and retrieval of instrument data,
reports and documents, together with an outline of its underlying technology.
The system was developed for deployment in data-intensive laboratories in
industries such as pharmaceuticals, chemical/petrochemicals, and food and
beverage. Launched in 2002, Thermo’s eRecordManager helps customers
to capture, store and index large volumes of laboratory data and associated
information, while also converting the content of these records for storage
as GAML (Generalized Analytical Markup Language) files based on XML (eXtensible
Mark-up Language) format. The brochure, which is illustrated by a series of
screen captures, is available free-of-charge worldwide to organizations that
are assessing their long-term analytical data archival and knowledge management
requirements. For details, visit http://www.thermolabsystems.com.
Autoscribe
Releases Matrix CRS - Compound Registration Systems
Autoscribehas released a suite of inventory programmes that range from simple
single workstation systems to global enterprise solutions. Matrix CRS will
allow the registration of all compounds with allocation of a unique identity
and the tracking of different batches and samples of a compound that may be
stored in different locations. Sample and container history can be maintained
and bar codes are fully supported. Matrix CRS also handles requests for compounds
and maintains the inventory levels as stock is removed and/or replenished.
The system can be interfaced to instruments such as balances for automatic
update of inventories and a plate handling facility can be added to the system.
Audit trailing, system security, version controlling of reference data and
electronic signatures are all part of the system. Matrix CRS is the latest
addition to the Matrix family of LIMS. For details, visit http://www.autoscribe.co.uk.
Autoscribe Announces Configurable Approach to
Managing Employee Training Needs
Many functionally comprehensive software applications are perceived as too
complex when not all of the functionality available is initially required.
This can increase demands on both training and ongoing support. Equally, adopting
a more basic solution can often cause escalating costs later, when upgrading
an application or migrating data. Autoscribe have developed an application
environment that aims to overcome many of these difficulties. By allowing
customers to tailor the user interface of Autoscribe applications, the user's
experience can be accurately matched to their current requirements. By using
a set of configuration tools the customer can easily add (or remove) functionality
by enabling or disabling parts of the user interface. The separation of the
user interface from the data and business logic also allows different application
clients to use both Windows and Web forms at the same time. Any changes made
to the user interface by use of the configuration tools are reflected in both
the Windows and Web forms simultaneously. Training Records Management is the
first application area to be featured in asequence of new Autoscribe applications
to use this development strategy. For details, visit http://www.autoscribe.co.uk.
Algorithme Pharma Purchases InnaPhase
Corporation's Watson LIMS in Canada
InnaPhase Corporation has announced that Algorithme Pharma has signed an agreement
to purchase Watson LIMS licenses and services for their research and development
center based in Montreal, Quebec, Canada. Watson LIMS, a solution within the
Pharma LIMS Suite, is specifically designed to support DMPK/Bioanalytical
studies in drug development while ensuring regulatory compliance with the
FDA's 21 CFR Part 11 guidance on electronic records and signatures. Watson
has an established track record of accelerating bioanalysis, sample management
and regulatory compliance in pharmaceutical drug development. "Algorithme
is committed to using the latest, most innovative technologies within our
laboratories in order to better serve our clients," said Troy Bradley,
Bioanalytical Director for Algorithme Pharma. "Watson LIMS allows us
to provide our customers the opportunity to bring their products and services
into the market quickly and efficiently while strictly respecting their deadlines
and budgets." "18 of the top 20 Pharmaceutical organizations worldwide
are using one or more of InnaPhase's solutions throughout their organizations
everyday," said Jo Webber, Ph.D., President and CEO of InnaPhase Corporation.
"Implementing Watson will allow Algorithme Pharma to quickly realize
the benefits of using the same technology as their customer base while maintaining
a competitive edge over other Contract Research Organizations worldwide."
Algorithme Pharma is a full-service Contract Research Organization specializing
in studies performed on healthy human volunteers. Their main activity sectors
are bioavailability and bioequivalence studies along with Phase I trials.
For details, visit http://www.innaphase.com.
ABB and Nicklas & Partner Join Together to
Provide Collaborative Production Management Solutions
ABB, a leading
power and automation technology group, and Nicklas & Partner, Inc (N&P),
a premier provider of service and support, engineering and application software
and hardware design, have announced a partnership. ABB and N&P are partnering
to better serve the North American cement industry with ABBís CPM solution
portfolio, enhanced with strong regional professional services. Rauli Hantikainen,
Head of ABB Industrial IT Solutions for Cement and Minerals Industries of
ABB Switzerland Ltd, said the partnership is an important step in implementing
ABBís strategy of providing comprehensive and truly integrated CPM
solutions for North American customers. N&P have offices in Alpharetta,
GA and Houston, TX, USA, as well as Turgi, Switzerland, and the parent company's
head office in Rˆmerberg, Germany. For details, visit http://www.np-e.com
or http://www.abb.com.
Bio-Rad
Announces New Software Technology for In-Silico ADME/Tox Consensus Modeling
Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of
life science research products and clinical diagnostics, has announced that
their Informatics Division has introduced a new ADME/Tox Consensus Modeling
Environment for use in in silico ADME/Tox screening. The new technology has
been integrated into the Company's KnowItAll Informatics System, used for
ADME/Tox prediction, spectroscopy data management, and cheminformatics. The
new Consensus Modeling Environment is a software technology that optimizes
the combined results of multiple in silico ADME/Tox models. The Consensus
Modeling Environment has the capacity for greater accuracy than any of the
individual models. Initially, the Consensus Modeling Environment will be applied
to two types of discrete prediction models˜log P (octanol/water partition
coefficient) and water solubility˜and one type of classification model˜mutagenicity.
Bio-Rad Informatics has entered into agreements with developers of these technologies
to deploy multiple models in the Consensus Modeling Environment. Bio-Rad eventually
plans to extend this technology into other predictive models of interest to
ADME/Tox investigators. For details, visit http://www.bio-rad.com.
Bio-Rad's
KnowItAll Informatics System 2.2 Offers Enhanced Features for NMR, MS, and
3D Structure Drawing
Bio-Rad Laboratories, Inc. Informatics Division has announced the release
of the KnowItAll Informatics System version 2.2, a major upgrade to this leading
software & database solution for spectroscopy, cheminformatics, and ADME/Tox
evaluation. Highlights and additions in the new release(s) include ProcessIt
NMR to import and process NMR spectra; ProcessIt MS to import and process
mass spectra and hyphenated techniques; and, SymApps, a software program that
converts 2-D chemical structure drawings to 3-D, and calculates, displays,
and animates the symmetry for a molecule. KnowItAll‚s ADME/Tox Edition
log P Prediction offers a neural network method in addition to atomic and
fragment for improved accuracy. Bio-Rad's Informatics Division specializes
in state-of-the-art software and database solutions for the pharmaceutical,
biotech, and chemical industries. For details, visit http://www.bio-rad.com.
JEOL
USA and ACD/Labs Introduce Automated Structure Elucidation for NMR
JEOL USA, Inc. and Advanced Chemistry Development, Inc. (ACD/Labs) have announce
the integration of JEOL’s Delta NMR and ACD/Structure Elucidator software
packages, resulting in the only complete system to combine data collection
and structure elucidation for automatically determining molecular structures.
NMR structure determination of small molecules is one of the most important
tools available to the synthetic chemist. NMR spectrometers automate data
collection, processing, and presentation, but until now, the actual structure
determination has been left to the chemist or an offline structure elucidation
software package. By directly coupling reduced NMR spectrometer output from
JEOL’s Delta software to ACD/Structure Elucidator, the time spent on
NMR structure determination is now reduced from several days to hours or minutes,
and the chemist is provided with a range of possible structures for a compound
that might otherwise be overlooked. ACD/Structure Elucidator has been built
on the combined strength of ACD/Labs’ NMR prediction and spectral data
interpretation software. Through a unique set of algorithms, ACD/Structure
Elucidator enables scientists to determine the chemical structure of unknown
compounds using data acquired from their NMR spectrometer or a combination
of analytical devices. Delta software is the only NMR software to combine
spectrometer control and data management into a single robust application
and allow concurrent processing of multiple sets and simple, seamless operation.
Featured with JEOL’s newest generation of high-resolution NMR spectrometers,
the ECA and ECX series, Delta unifies NMR data acquisition, processing, visualization,
and output. For greater flexibility, Delta operates in both Windows and Linux
environments. For details, visit http://www.jeol.com.
Agilent
Technologies to Integrate its HPLC and ChemStation Solutions with Advanced
Chemistry Development's AutoChrom and ChromGenius Software
Agilent Technologies Inc. and Advanced Chemistry Development Inc. (ACD/Labs)
have announced an agreement to develop and market the integration of ACD/Labs
AutoChrom and ChromGenius software with the Agilent ChemStation software and
1100 Series HPLC systems. The agreement is expected to benefit analytical
laboratories in a wide range of industries by providing a faster and more
productive way to develop analysis methods for high-throughput applications.
ACD/Labs' forthcoming AutoChrom will be a fully automated version of ACD/Labs
Method Development Suite, a complete package of ACD/Labs tools for databasing,
sharing, processing, and optimizing chromatographic applications, as well
as for developing new separation methods based on chemical structures and
retained chromatographic knowledge. The first release of ACD/Labs AutoChrom
will only be compatible with Agilent ChemStation. This agreement also provides
ChemStation users with the ability to push task lists from ACD/Labs ChromGenius
to ChemStation. ACD/Labs ChromGenius is a generic method selection tool for
high-throughput chromatography that determines appropriate separation methods
based on analyte structure and pre-experimental calculations. ACD/Labs software
currently supports Agilent's electronic formats for liquid chromatography
(LC) and mass spectrometry (MS) data, enabling scientists to import data seamlessly
from Agilent ChemStation into ACD/Labs ChromManager or Method Development
Suite. Both ACD/Labs products come equipped with the ACD/Labs Chromatography
Applications Database, which comprises over 4,800 applications, including
those developed on Agilent columns. Users can retrieve suitable separation
methods for an analyte by conducting structure similarity and substructure
searches on existing Agilent methods or methods imported from ChemStation.Agilent
ChemStation is a family of networked data systems that provides modular software
components for instrument control, data acquisition and data management, with
the flexibility to meet both a lab's present and future requirements. The
ChemStation base software handles applications such as LC, LC/MS, gas chromatography,
capillary electrophoresis, and capillary electrophoresis/mass spectrometry,
and can be extended with add-on software modules for data organization and
storage, remote control and monitoring, compliance with FDA 21 CFR Part 11,
and validation of analytical methods. For details, visit http://www.acdlabs.com
or http://www.agilent.com.
Agilent Technologies Reports Third-Quarter
2003 Results; Company on Track to Achieve Profitability in Fourth Quarter
Agilent Technologies Inc. reported orders of $1.47 billion and revenue of
$1.50 billion for the fiscal third quarter ended July 31, 2003. During the
quarter, the company recognized a $1.4 billion non-cash charge required under
Statement of Financial Accounting Standards No. 109, "Accounting for
Income Taxes," and reported a GAAP net loss of $1.56 billion, or $3.28
per share. Excluding that charge, the company would have reported a loss from
operations of $110 million, or $0.23 per share, which compares to a GAAP loss
of $223 million, or $0.48 per share, one year ago. Also excluding $99 million
of net restructuring charges and intangibles amortization, Agilent reported
a net loss for the third quarter of $11 million, or $0.02 per share, versus
a loss on a comparable basis of $0.31 per share one year ago. "We are
encouraged by our third-quarter operating results," said Ned Barnholt,
Agilent chairman, president and chief executive officer. "Orders and
revenues came in at expectations, with earnings from operations near the top
end of expectations. We are confident that we'll meet our commitment to achieve
an operating breakeven cost structure of $1.45 billion and return to profitability
in the fourth quarter of this year." Agilent saw a continued rebound
this quarter in semiconductor equipment orders, which reached their highest
level in three years. Activity in the company's other segments remained roughly
flat compared to the prior year. "We made good progress in continuing
to reduce our structural costs," Barnholt said. "These costs were
reduced by nearly $100 million during the quarter, while worldwide headcount
fell by an additional 2,400 during the last three months." Continued
progress was also reflected on the balance sheet. The company generated $38
million cash from working capital during the quarter despite sequentially
higher revenues. Capital spending, at $62 million, remained below depreciation
expense of $77 million. Net cash consumption was only $103 million despite
$121 million of cash restructuring payments. The company ended the quarter
with over $1.4 billion in cash and equivalents. Looking ahead, Barnholt said,
"We are seeing more evidence of a sustainable upturn in semiconductor
capital equipment, and in the underlying semiconductor markets." Overall,
the company anticipates a normal seasonal increase during the fiscal fourth
quarter, with revenues in the range of $1.50 billion to $1.60 billion. Earnings
before restructuring and amortization charges are expected to be in a range
of an operating breakeven to $0.10 per share. "Our fourth-quarter priority
remains firmly focused on achieving a $1.45 billion operating breakeven cost
structure, which will lay the foundation for sustained profitability in 2004,"
Barnholt said. For details, visit http://www.agilent.com.
Labtronics Announces Software
Upgrade for Technicon AAII and Alpkem RFA Instruments
Labtronics Inc has announced the release of an all new version of NAP, their
data collection and analysis software for Technicon AAII and Alpkem RFA instruments.
NAP 4.0 is a full 32 bit application for the Windows 2000 and Windows XP Professional
platforms that provides a complete data system for continuous flow and flow
injection analyzers. The new version features an all new hardware configuration
that uses USB technology to maintain a high-speed connection between the instrument
and the PC, without having to install any components inside the PC. Simply
plug in and start processing. This not only simplifies setup it also provides
users with the option of running NAP on a laptop or notebook PC. NAP 4.0 also
provides a new direct connection with MicroSoft Excel. NAP can now automatically
launch Excel, open a worksheet using a pre-defined template and fill the spreadsheet
with the run results. The full processing power of Excel can then be used
to further process the data. For details, visit http://www.labtronics.com.
Caliper Technologies Acquires Zymark Corporation
Caliper Technologies Corp.has acquired Zymark Corporation,
a privately-held provider of laboratory automation, liquid handling and robotics
solutions to the life sciences, biotechnology and pharmaceutical industries.
The combined company will offer a state-of-the-art, comprehensive portfolio
of laboratory automation products with a global commercial infrastructure
to provide customers with highly innovative solutions for accelerating drug
discovery and development in the life sciences, pharmaceutical and biotechnology
industries. As a result of the acquisition, Zymark has become a wholly-owned
subsidiary of Caliper and will continue to sell products under its own name.
Under the final terms of the deal, Caliper has purchased Zymark for approximately
$57 million and 3.15 million shares of Caliper common stock. The agreement
also provides for a potential additional earn-out stock component of up to
1.575 million shares of Caliper stock if specified targets for sales of Zymark
products are met in 2003 and 2004. For details, visit http://www.calipertech.com
or http://www.zymark.com.
Oracle
Introduces Several New Products
Oracle Corporation has introduced the Oracle Database 10g, a new software
designed to help customers and partners achieve the highest levels of efficiency
from their Information Technology (IT) investments, including hardware, software
and, most importantly, labor. Oracle Database 10g relieves IT professionals
from time-consuming, repetitive administrative work, enabling them to focus
more on solving business problems. Oracle has also announced Oracle Application
Server 10g and Oracle Enterprise Manager 10g. Together, they comprise Oracle
Grid Computing, one of the first integrated grid infrastructure software products
on the market. Oracle Enterprise Manager 10g introduces automated management
software that provides a complete view of a company's computing infrastructure.
System administrators can enforce policies, manage service levels, and rebalance
existing computing resources and applications as business requirements change.
For details, visit http://www.oracle.com.
SAP Expands mySAP Customer
Relationship Management (mySAP CRM)
SAP has outlined its new and enhanced CRM analytics offering as part of the
latest version of mySAP Customer
Relationship Management (mySAP CRM) announced in June. New capabilities in
mySAP CRM include real-time analytics to leverage customer insight during
each customer interaction; marketing optimization to boost response rates;
sales, marketing and service business planning to closely measure performance
against strategic targets; and out-of-the-box analytics scenarios. By enabling
deep integration with multiple sources and applications across the enterprise,
organizations can now better measure and predict customer actions by transforming
raw information into business strategies for optimizing the most profitable
customer relationships. The new analytics capabilities in mySAP CRM enable
companies to extract more business value from their wealth of transactional
data to better understand customers and the products they want, at what price,
and under what conditions. For details, visit http://www.sap.com.
SAP Supports WS-I Basic Profile 1.0
SAP has announced its support for the first release of the WS-I BasicP rofile
1.0 (BP 1.0), a set of implementation guidelines for companies to utilize
a set of core Web services specifications to develop interoperable Web services.
The Web Services Interoperability Organization (WS-I) brings the work of multiple
standards organizations (such as W3C and OASIS) together for the purpose of
providing clarity and guidance around Web services interoperability. As a
founding WS-I Board member, SAP actively participated in the development of
the BP 1.0 and will support the new guidelines throughout their implementation
and industry adoption. The SAP NetWeaver technology platform, which drives
lower cost of ownership across heterogeneous IT landscapes, corresponds to
the BP 1.0 and allows SAP customers to develop, deploy, and integrate enterprise
applications in alignment with the new implementation guidelines. Through
SAP's support of the BP 1.0, customers can operate directly with the new implementation
guidelines, rather than dealing with the individual Web services specifications,
such as SOAP (Simple Object Access Protocol), WSDL (Web Services Description
Language) and UDDI (Universal Description, Discovery and Integration). For
details, visit http://www.sap.com.
FDA Applies Risk-Based Approach
to Preapproval Inspections
Aiming to reduce the number of preapproval inspections (PAI) and leverage
resources for higher-risk inspections, the FDA has announced changes to its
inspection program to give field officers more flexibility in determining
whether a PAI is necessary. According to Center for Drug Evaluation and Research
(CDER), the strategy of assigning PAIs now includes two general categories:
those that will regularly prompt an inspection request from CDER, and those
where the district office may choose to perform an inspection. CDER deleted
categories mandating inspections for narrow therapeutic range drugs and for
generic versions of the top 200 prescription drugs. The revised inspection
strategy -- incorporated into the Preapproval Inspections/ Investigations
section of the Compliance Program Guidance Manual -- provides district field
officers with "greater flexibility in determining if a preapproval inspection
is necessary based on the most current knowledge and [current good manufacturing
practice] status of a firm," the agency said in a statement. Under the
changes, regular inspections will be carried out in nine specific categories,
including new molecular entities, priority new drug applications, and for
firms that have not been inspected in the past two years. Outside of the nine
areas, the district office may determine on its own if a preapproval inspection
is warranted. For details, visit http:///www.fda.gov.
FDA's cGMP Initiative Aims to Boost
Safety, Efficiency
The FDA has announced the formation of a special inspection team, changes
in its preapproval inspection program, and the release of four draft guidances
and a final guidance on various manufacturing issues as part of a continuing
effort to improve current good manufacturing practices (cGMPs). The agency
hopes these steps will help make pharmaceutical manufacturing "more efficient
and safer," FDA Commissioner Mark McClellan said. The guidances are intended
to help the pharma industry and the agency "focus their efforts where
they are most beneficial, on critical and risky areas," he said. The
five guidances, published in today's Federal Register, were:
- A draft guidance establishing a dispute resolution process for science and
technical issues related to cGMPs;
- A draft guidance setting guidelines for using comparability protocols to
implement changes in manufacturing processes after obtaining marketing approval
for protein-based human and veterinary drugs and biological products;
- A draft guidance establishing a regulatory framework to encourage voluntary
implementation of new manufacturing and quality assurance technologies;
- A draft guidance updating recommendations on aseptic processing for sterile
drug products; and
- A final guidance outlining the FDA's enforcement of 21 CFR Part 11, dealing
with electronic records and signatures.
The guidances and other actions are part of a two-year agency initiative,
"Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach,"
launched in August 2002. For details, visit http:///www.fda.gov.
FDA Releases Part 11 Guidance,
More Revisions May Come
The FDA yesterday released the final guidance on 21 CFR Part 11, the regulation
dealing with electronic records and signatures, promising to re-examine the
underlying regulation and initiate rulemaking in coming months to revise provisions
of Part 11. While promising to narrow Part 11's scope and selectively enforce
its requirements as the agency reviews the regulation, the FDA stressed that
Part 11 remains in effect and its enforcement discretion applies only to points
outlined in the guidance. In addition, manufacturers must adhere to all predicate
rule requirements, whether or not their systems are ultimately subject to
Part 11. The document was released as part of the broader current good manufacturing
practices (cGMP) risk-based initiative. To purchase full FDAnews coverage
of the Part 11 guidance and other stories relating to the cGMP initiative
in Drug Industry Daily go to http://www.fdanews.com/pub/did.
To view the final guidance, "Part 11, Electronic Records; Electronic
Signatures - Scope and Application," published in the Federal Register,
go to http://www.fda.gov/OHRMS/DOCKETS/98fr/5667fnl.pdf.
FDA, GPhA Launch ANDA Review Cycle
Initiative
The FDA's Office of Generic Drugs (OGD) and the Generic Pharmaceutical Association
(GPhA) have launched a collaborative initiative to help speed generic drug
approvals by reining in the number of review cycles. Project First Review
Cycle aims to foster dialogue between OGD and generic drugmakers about correcting
mistakes in abbreviated new drug applications (ANDAs) that now result in multiple
review cycles. Meetings with OGD experts will be held every two or three months,
and be open to all GPhA members. The first will be held Sept. 24 in the Washington,
D.C., area, according to GPhA. In recent years, 93 percent of ANDAs were not
approved on the first review, while 66 percent were not approved after the
second cycle. Each review cycle means months of delay and millions of dollars
in additional development costs, FDA Commissioner Mark McClellan said. For
details, visit http:///www.fda.gov.